Proposed CMS national coverage decisions for the use to erythropoiesis stimulating agents (ESAs) in cancer and related neoplastic conditions, on privately-sponsored post-approval clinical trials, and the Inpatient Prospective Payment System. Proposed CMS national coverage decisions for the use to erythropoiesis stimulating agents (ESAs) in cancer and related neoplastic conditions, on privately-sponsored post-approval clinical trials, and the Inpatient Prospective Payment System. H.R.2138, The Investment in America Act of 2007; S.41, The Research Competitiveness Act of 2007
HCR - Health Issues MMM - Medicare/Medicaid TAX - Taxation/Internal Revenue Code
11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE
THE HOBBS GROUP, LLC
300 NEW JERSEY AVENUE NW, SUITE 601, WASHINGTON, DC, 20001, US
DAVID HOBBS (Assistant to the President for Legislative Affairs) DAVID HOBBS (Assistant to the President for Legislative Affairs) DAVID HOBBS (Assistant to the President for Legislative Affairs)
Assistant to the President for Legislative Affairs Assistant to the President for Legislative Affairs Assistant to the President for Legislative Affairs